Last reviewed · How we verify
NCT04785482: PaTHS
The PaTHS Descriptive Correlational Longitudinal Study
trial in Single-ventricle in 22 participants. Completed in 9 June 2022.
9 June 2022
Quick facts
| Lead sponsor | Children's Mercy Hospital Kansas City |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 22 |
| Start date | 1 March 2021 |
| Primary completion | 9 June 2022 |
| Estimated completion | 9 June 2022 |
| Sites | 1 location across United States |
Conditions studied
- Single-ventricle — all drugs for Single-ventricle →
- Posttraumatic Stress Disorder — all drugs for Posttraumatic Stress Disorder →
- Psychosocial Impairment — all drugs for Psychosocial Impairment →
Sponsor
Children's Mercy Hospital Kansas City
Who can join
Eligibility, any sex, with Single-ventricle or Posttraumatic Stress Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of this study is to measure parent's post-traumatic stress before and after their infant's second palliative heart surgery for single ventricle congenital heart disease. The investigators will use the posttraumatic stress disorder checklist for the DSM-V (PCL-5) to measure levels 2-4 weeks before and after the infant's second heart surgery. The investigators aim to describe the levels at the two-time points, compare the scores, and identify demographic information that correlates with the scores.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04785482
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Single-ventricle
Currently open trials in the same condition.
- NCT07073612 — Transcatheter Fontan Stenting: Impact on Hepatic Stiffness and Exercise Capacity · recruiting
- NCT06434207 — Extracellular Vesicle Micro RNA Profiling in Congenital Heart Disease: Fetal-Maternal Regulation in Neonatal Thrombosis · recruiting
- NCT06613477 — PK/PD of Digoxin in Infants With SVHD · Phase 1, PHASE2 · recruiting
- NCT06538571 — Association of Near Infrared Spectroscopy With Interstage Outcomes · NA · recruiting
- NCT06150950 — REHAB Fontan Failure: A Trial of Cardiac Rehabilitation · NA · recruiting
Other Children's Mercy Hospital Kansas City trials
Trials by the same sponsor.
- NCT07458568 — ViBandz Feasibility Study · not yet recruiting
- NCT07195032 — Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Pediatric Heart Transplantation Patients · Phase 4 · recruiting
- NCT06834594 — Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome · Phase 4 · recruiting
- NCT06738121 — Cosmetic Outcomes of Umbilical Hernia Incisions · NA · completed
- NCT06520657 — Addressing Social Determinants of Health in Child Obesity Treatment Using Community Health Workers · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04785482 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Children's Mercy Hospital Kansas City
- Last refreshed: 22 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04785482.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing